Developing a transdermal formulation of an approved osteoporosis treatment.
Industry: Health Care
First Day Return: +0.1%
IPO Data | |
---|---|
IPO Date | 01/26/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Fremont, CA, United States |
Founded | 2007 |
Employees at IPO | 29 |
Website www.zosanopharma.com |